IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
about
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesAnimal models to study gluten sensitivityCoeliac disease: a unique model for investigating broken tolerance in autoimmunityNon-celiac gluten sensitivity: literature reviewHuman monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling.IL-15: a central regulator of celiac disease immunopathology.IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes.Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients.Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.Distribution of CD4(pos) -, CD8(pos) - and regulatory T cells in the upper and lower gastrointestinal tract in healthy young subjects.Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation.Immunopathogenesis of olmesartan-associated enteropathy.Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.Cytokine levels in the serum of healthy subjectsInterleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaIn vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.Intraepithelial lymphocytes in celiac disease immunopathology.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Immunotherapeutic applications of IL-15.Latest in vitro and in vivo models of celiac disease.IL-17 producing T cells in celiac disease: angels or devils?Lessons from rodent models in celiac disease.Are stem cells a potential therapeutic tool in coeliac disease?How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy.miRNAs affect the expression of innate and adaptive immunity proteins in celiac disease.Effector and suppressor T cells in celiac disease.Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet.Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences?Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study
P2860
Q26746677-62B267F4-5CEF-4426-A047-7ACC02B60A97Q26859130-D0EA5A0B-8336-4482-895C-714BD0BA0978Q28073430-34E31063-E5DC-4B9C-9E6C-0256F68C51EFQ28307766-FE668C8C-A06F-43CB-AA53-5B4879B58F3EQ33601367-D75CCE9B-81FE-4C68-B8CF-CE627F24F4E6Q33788829-83EA5ED3-3A62-4F45-90AB-566C738E9EA4Q33858357-2BE5DE8C-93FA-4AF1-8F87-D26B866B3E8FQ34447313-9876BDB1-49CE-465F-AB12-EE076B67A412Q34848590-39C48389-0F74-4007-84A8-251CD4CD231DQ34932408-BD12D6C3-321A-42C1-BD1E-C81966A85D48Q35050631-89F36D2B-8C15-4C0B-9E6B-1362EFBD5322Q36132402-AEDFB366-414E-44DB-A131-7833F66DE177Q36225350-DC860F1C-83AA-499E-8A3C-F80018FCFC20Q36675105-796BFD57-8C07-4174-8482-DF73AB6F62D5Q36711758-C279AADF-D9E0-413D-9AA8-B36490FB5263Q36956269-69BACC49-C4A6-4CDE-809D-CA14BA5E74EEQ37979161-67AF7EAB-80AF-4F05-B0F3-6262ADA82BB3Q38015720-0DC80565-9D5C-44B3-B2C5-B68414F788BEQ38016781-1E9B5694-B800-4F8B-B00A-B365D92F637FQ38050510-87E51EAA-E6F4-4538-A663-F88A73BF1E00Q38072065-150158E8-E7E5-4957-BD1C-AFF0B518CAD7Q38138107-15D1FD78-7FB8-424E-8BB4-039A227705D5Q38263650-61C453F9-07A0-49F1-B4BC-B583D33EEE60Q38289416-CC9FAA9E-ADDA-4BCE-B867-0FDE2A4D4E71Q38852283-34CFB364-7F7A-40B6-A378-42B19A8AEBB3Q41247751-3F852BA0-FC6C-4EA2-A16C-76771E2FA5E8Q42204189-657147BE-05AE-4E9C-8AE8-421E6484470EQ42403528-8FFA9D0F-BB05-4161-ABA2-A23BFCA5782EQ42505722-0C7737C9-53CD-44D2-B15D-6A12F989F743Q48364966-E11F0E68-7553-4D69-B3CB-9948E14F5E44Q50769349-E8ED771B-9A8F-42C1-B4C9-94A64C596E36Q54337749-D3C655B7-85A4-4CA2-B21B-E75D747CF771Q55222890-A0B7B5BE-98BF-44C0-A4C9-C8F5C45B6D77Q57937529-0C0B989B-232F-412C-9CCA-DE367FE050FC
P2860
IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@en
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@nl
type
label
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@en
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@nl
prefLabel
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@en
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@nl
P2093
P2860
P356
P1476
IL-15 interferes with suppress ...... ls expanded in Celiac disease.
@en
P2093
Aufiero Rotondi Vera
Delia Zanzi
Gaetano Iaquinto
Giuliana Lania
Giuseppe Mazzarella
Ilaria Vigliano
Katia Ferrara
Laura Iaffaldano
Nicola Giardullo
Riccardo Troncone
P2860
P304
P356
10.1038/AJG.2011.80
P407
P577
2011-04-05T00:00:00Z